p53 promotes selection for Fas-mediated apoptotic resistance

被引:0
|
作者
Maecker, HL
Koumenis, C
Giaccia, AJ
机构
[1] Stanford Univ, Med Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC 27157 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although p53 inactivation is implicated as a mechanism to explain diminished apoptotic response, it is clear that tumor cells that possess transcriptionally functional p53 can also be resistant to diverse apoptotic stimuli, We hypothesize that oncogenic activation and DNA damage are sufficient stimuli to increase the p53-dependent transcription of Fas and thereby establish a situation in which cell to cell contact could be a selective pressure to either lose p53 function or inactivate components of the Fas death pathway. Examination of genetically matched tumor cell lines that possessed either wild-type or null p53 loci indicated that cells possessing functional p53 increased their surface levels of Fas and Fas ligand (FasL) in response to DNA damage. In contrast, stress induced by changes in the tumor microenvironment such as decreased oxygen did not up-regulate Fas or Fast. Cells with wild-type p53 underwent Fas-mediated killing in the presence of either Fast-expressing killer cells or activating Fas antibodies, whereas cells in which p53 was deleted or inactivated were protected from such killing. Furthermore, Fas and Fast expression and induction became transcriptionally repressed in transformed cells with wild-type p53 with increasing passage, whereas other p53 downstream targets and functions, such as p21 inducibility and cell cycle arrest, remained intact. Repression of the Fas Locus could be reverted by treatment with the histone deacetylase inhibitor trichostatin A. These results support a model of tumor progression in which oncogenic transformation drives tumor cells to lose either p53 or their Fas sensitivity as a means of promoting their survival and evade immune surveillance.
引用
收藏
页码:4638 / 4644
页数:7
相关论文
共 50 条
  • [1] p53 promotes selection for Fas-mediated apoptotic resistance.
    Maecker, HL
    Koumenis, C
    Giaccia, AJ
    FASEB JOURNAL, 2000, 14 (06): : A1014 - A1014
  • [2] Selection for drug resistance results in resistance to Fas-mediated apoptosis
    Landowski, TH
    GleasonGuzman, MC
    Dalton, WS
    BLOOD, 1997, 89 (06) : 1854 - 1861
  • [3] The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites
    Longley, DB
    Allen, WL
    McDermott, U
    Wilson, TR
    Latif, T
    Boyer, J
    Lynch, M
    Johnston, PG
    CLINICAL CANCER RESEARCH, 2004, 10 (10) : 3562 - 3571
  • [4] Fas-mediated apoptosis and p53 mutation in a Hodgkin's disease cell line
    Kubonishi, I
    Furihata, M
    Kamioka, M
    Sonobe, H
    Ohtsuki, Y
    Miyoshi, I
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) : 1048 - 1049
  • [5] Involvement of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial cells.
    Itoh, K
    Hase, H
    Saotome, K
    Nishioka, K
    Kobata, T
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S102 - S102
  • [6] Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts
    Itoh, K
    Hase, H
    Kojima, H
    Saotome, K
    Nishioka, K
    Kobata, T
    RHEUMATOLOGY, 2004, 43 (03) : 277 - 285
  • [7] Altered trafficking of Fas and subsequent resistance to Fas-mediated apoptosis occurs by a wild-type p53 independent mechanism in esophageal adenocarcinoma
    Mahidhara, RS
    De Oliveira, PEQ
    Kohout, J
    Beer, DG
    Lin, JY
    Watkins, SC
    Robbins, PD
    Hughes, SJ
    JOURNAL OF SURGICAL RESEARCH, 2005, 123 (02) : 302 - 311
  • [8] The Fas-Mediated Apoptotic Pathway in Cardiac Myxoma
    Liu, Cheng-Chung
    Jung, Shih-Ming
    Orlandi, Augusto
    Yeh, Ta-Sen
    Lin, Yu-Shen
    Shiu, Tzu-Fang
    Wu, Hsueh-Hua
    Chu, Jaw-Ji
    Lin, Pyng-Jing
    Chu, Pao-Hsien
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2010, 18 (06) : 493 - 498
  • [9] Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide
    Senatus, PB
    Li, Y
    Mandigo, C
    Nichols, G
    Moise, G
    Mao, YH
    Brown, MD
    Anderson, RC
    Parsa, AT
    Brandt-Rauf, PW
    Bruce, JN
    Fine, RL
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (01) : 20 - 28
  • [10] Fas-mediated apoptosis with normal expression of bcl-2 and p53 in lymphocytes from aplastic anaemia
    Callera, F
    Garcia, AB
    Falcào, RP
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (04) : 698 - 703